Nancy Y Chen1, Eugene Nguyen2, Sheree M Schrager2, Christopher J Russell2,3. 1. Division of Hospital Medicine, Phoenix Children's Hospital, Phoenix, Arizona; nchen1@phoenixchildrens.com. 2. Division of Hospital Medicine, Children's Hospital Los Angeles, Los Angeles, California; and. 3. Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California.
Abstract
OBJECTIVE: Identify factors associated with the prophylactic prescription of a bowel regimen with an inpatient opioid prescription. METHODS: This was a retrospective cohort study from June 1, 2013, to October 31, 2014 of pediatric inpatients prescribed an oral or intravenous opioid on the general medical/surgical floors. We identified patients with or without a prophylactic prescription of a bowel regimen. We obtained patient demographics, prescriber training level and service and used multivariate logistic regression to analyze the factors associated with prophylactic bowel regimen and opioid prescription. RESULTS: Of the 6682 encounters that met study criteria, only 966 (14.5%) encounters had prophylactic prescriptions. Patient factors associated with prophylactic prescription include increasing age (per year; odds ratio [OR] = 1.06, 95% confidence interval [CI] 1.05-1.07) and sickle cell diagnosis (OR = 3.19, 95% CI 2.08-4.91). Medication factors associated with prophylactic prescription include a scheduled opioid prescription (OR = 1.75, 95% CI 1.46-2.1) and a prescription for oxycodone (OR = 3.59, 95% CI 2.57-5.00) or morphine (OR = 1.84, 95% CI 1.39-2.44), compared with acetaminophen-hydrocodone. Compared with medical providers, surgeons were less likely (OR = 0.43, 95% CI 0.35-0.53) and pain service providers were more likely to prescribe a prophylactic bowel regimen (OR = 4.12, 95% CI 3.13-5.43). CONCLUSIONS: More than 85% of inpatient opioid prescriptions did not receive a prophylactic bowel regimen. Future research should examine factors (eg, clinical decision support tools) to increase prophylactic prescription of bowel regimens with opioids for populations found to have lower rates.
OBJECTIVE: Identify factors associated with the prophylactic prescription of a bowel regimen with an inpatient opioid prescription. METHODS: This was a retrospective cohort study from June 1, 2013, to October 31, 2014 of pediatric inpatients prescribed an oral or intravenous opioid on the general medical/surgical floors. We identified patients with or without a prophylactic prescription of a bowel regimen. We obtained patient demographics, prescriber training level and service and used multivariate logistic regression to analyze the factors associated with prophylactic bowel regimen and opioid prescription. RESULTS: Of the 6682 encounters that met study criteria, only 966 (14.5%) encounters had prophylactic prescriptions. Patient factors associated with prophylactic prescription include increasing age (per year; odds ratio [OR] = 1.06, 95% confidence interval [CI] 1.05-1.07) and sickle cell diagnosis (OR = 3.19, 95% CI 2.08-4.91). Medication factors associated with prophylactic prescription include a scheduled opioid prescription (OR = 1.75, 95% CI 1.46-2.1) and a prescription for oxycodone (OR = 3.59, 95% CI 2.57-5.00) or morphine (OR = 1.84, 95% CI 1.39-2.44), compared with acetaminophen-hydrocodone. Compared with medical providers, surgeons were less likely (OR = 0.43, 95% CI 0.35-0.53) and pain service providers were more likely to prescribe a prophylactic bowel regimen (OR = 4.12, 95% CI 3.13-5.43). CONCLUSIONS: More than 85% of inpatient opioid prescriptions did not receive a prophylactic bowel regimen. Future research should examine factors (eg, clinical decision support tools) to increase prophylactic prescription of bowel regimens with opioids for populations found to have lower rates.
Authors: Paul J Sharek; Richard E McClead; Carol Taketomo; Joseph W Luria; Glenn S Takata; Beverly Walti; Marla Tanski; Carla Nelson; Tina R Logsdon; Cary Thurm; Frank Federico Journal: Pediatrics Date: 2008-10 Impact factor: 7.124
Authors: Timothy J Brown; Neil Keshvani; Arjun Gupta; Hui Yang; Deepak Agrawal; Tri C Le; David E Gerber; Carlos A Alvarez Journal: Support Care Cancer Date: 2020-03-02 Impact factor: 3.603
Authors: Samina Ali; Katie Gourlay; Aran Yukseloglu; Rhonda J Rosychuk; Silvia Ortiz; Rick Watts; David W Johnson; Bruce Carleton; Sylvie Le May; Amy L Drendel Journal: BMJ Paediatr Open Date: 2022-05-24